BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 15957612)

  • 1. HIF2α activation and mitochondrial deficit due to iron chelation cause retinal atrophy.
    Kong Y; Liu PK; Li Y; Nolan ND; Quinn PMJ; Hsu CW; Jenny LA; Zhao J; Cui X; Chang YJ; Wert KJ; Sparrow JR; Wang NK; Tsang SH
    EMBO Mol Med; 2023 Feb; 15(2):e16525. PubMed ID: 36645044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal imaging in a case of deferoxamine-induced maculopathy.
    Gelman R; Kiss S; Tsang SH
    Retin Cases Brief Rep; 2014; 8(4):306-9. PubMed ID: 25372534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and therapeutic challenges.
    Keane PA; Denniston AK; Elsherbiny SM; Freund KB; Moorthy R
    Retina; 2012 Jan; 32(1):197-202. PubMed ID: 22203336
    [No Abstract]   [Full Text] [Related]  

  • 4. Temporal and spectral electrooculographic features in a discrete precision task.
    Gallicchio G; Ryu D; Krishnani M; Tasker GL; Pecunioso A; Jackson RC
    Psychophysiology; 2024 Mar; 61(3):e14461. PubMed ID: 37855151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron Accumulation and Lipid Peroxidation in the Aging Retina: Implication of Ferroptosis in Age-Related Macular Degeneration.
    Zhao T; Guo X; Sun Y
    Aging Dis; 2021 Apr; 12(2):529-551. PubMed ID: 33815881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal abnormalities in β-thalassemia major.
    Bhoiwala DL; Dunaief JL
    Surv Ophthalmol; 2016; 61(1):33-50. PubMed ID: 26325202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oral iron chelator deferiprone protects against systemic iron overload-induced retinal degeneration in hepcidin knockout mice.
    Song D; Zhao L; Li Y; Hadziahmetovic M; Song Y; Connelly J; Spino M; Dunaief JL
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4525-32. PubMed ID: 24970260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Oral Iron Chelator Deferiprone Protects Against Retinal Degeneration Induced through Diverse Mechanisms.
    Hadziahmetovic M; Pajic M; Grieco S; Song Y; Song D; Li Y; Cwanger A; Iacovelli J; Chu S; Ying GS; Connelly J; Spino M; Dunaief JL
    Transl Vis Sci Technol; 2012; 1(3):2. PubMed ID: 24049709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Oral Iron Chelator Deferiprone Protects Against Retinal Degeneration Induced through Diverse Mechanisms.
    Hadziahmetovic M; Pajic M; Grieco S; Song Y; Song D; Li Y; Cwanger A; Iacovelli J; Chu S; Ying GS; Connelly J; Spino M; Dunaief JL
    Transl Vis Sci Technol; 2012; 1(2):7. PubMed ID: 24049707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic administration of the iron chelator deferiprone protects against light-induced photoreceptor degeneration in the mouse retina.
    Song D; Song Y; Hadziahmetovic M; Zhong Y; Dunaief JL
    Free Radic Biol Med; 2012 Jul; 53(1):64-71. PubMed ID: 22579919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oral iron chelator deferiprone protects against iron overload-induced retinal degeneration.
    Hadziahmetovic M; Song Y; Wolkow N; Iacovelli J; Grieco S; Lee J; Lyubarsky A; Pratico D; Connelly J; Spino M; Harris ZL; Dunaief JL
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):959-68. PubMed ID: 21051716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EOG as a monitor of desferrioxamine retinal toxicity.
    Hidajat RR; McLay JL; Goode DH; Spearing RL
    Doc Ophthalmol; 2004 Nov; 109(3):273-8. PubMed ID: 15957612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deferoxamine-related ocular toxicity: incidence and outcome in a pediatric population.
    Baath JS; Lam WC; Kirby M; Chun A
    Retina; 2008 Jun; 28(6):894-9. PubMed ID: 18536609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow-up.
    Salu P; Uvijls A; van den Brande P; Leroy BP
    Doc Ophthalmol; 2010 Jun; 120(3):251-64. PubMed ID: 20397038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expanded clinical spectrum of deferoxamine retinopathy.
    Haimovici R; D'Amico DJ; Gragoudas ES; Sokol S;
    Ophthalmology; 2002 Jan; 109(1):164-71. PubMed ID: 11772599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and Structural Abnormalities in Deferoxamine Retinopathy: A Review of the Literature.
    Di Nicola M; Barteselli G; Dell'Arti L; Ratiglia R; Viola F
    Biomed Res Int; 2015; 2015():249617. PubMed ID: 26167477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retinopathy caused by interferon alpha associated with ribavirin therapy and the importance of the electro-oculogram: a case report].
    Crochet M; Ingster-Moati I; Even G; Dupuy P
    J Fr Ophtalmol; 2004 Mar; 27(3):257-62. PubMed ID: 15039627
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.